Jersey Shore University Medical Center Cardiac Team Performs Rare, Lifesaving Combined Procedures

Experts from Hackensack Meridian Jersey Shore University Medical Center’s Structural Heart Disease Program recently performed, to the program’s knowledge, New Jersey’s first transcatheter double heart valve replacement, combined with a procedure to improve blood flow in the heart. The three treatments were completed together during one visit to the academic medical center’s advanced hybrid operating room, to ensure the patient’s safety.

Wearable Electronics for Continuous Cardiac, Respiratory Monitoring

A small and inexpensive sensor, announced in Applied Physics Letters and based on an electrochemical system, could potentially be worn continuously by cardiac patients or others who require constant monitoring. A solution containing electrolyte substances is placed into a small circular cavity that is capped with a thin flexible diaphragm, allowing detection of subtle movements when placed on a patient’s chest. The authors suggest their sensor could be used for diagnosis of respiratory diseases.

Jersey Shore University Medical Center Launches Cardio-Oncology Program

Hackensack Meridian Jersey Shore University Medical Center recently launched a Cardio-Oncology Program providing cancer patients and survivors access to cardiology and oncology specialists and advanced imaging services. L. Steven Zukerman, M.D., FACC, serves as medical director of the program, designed to minimize the impact of cancer treatments on patients’ hearts and provide continuing cardiac care to cancer survivors.

New COVID-19 Editorial: Examining Heart Issues After Recovery

In an article published online on June 26 in the journal Heart Rhythm, lead author Raul Mitrani, M.D., and co-authors with the University of Miami Miller School of Medicine’s Division of Cardiovascular Medicine, examine the varied cardiovascular injuries and complications that patients who have recovered from the acute COVID-19 infection may experience largely based on evidence from other viral infections or inflammatory injury to the heart. The authors also recommend developing screening and tracking measures to detect cardiac injury and potentially mitigate long-term impact.

MacNeal Hospital Launches First Clinical Trial in Illinois of Novel Monitoring Device for Congestive Heart Failure Patients

MacNeal Hospital is the first hospital in Illinois to participate in a national, randomized clinical trial using daily vital signs and lung pressure measurement to manage patients with congestive heart failure (CHF). The PROACTIVE-HF trial utilizes a new monitoring system, coupled with a pressure sensor, implanted directly into a blood vessel in the lung. This system provides information that is recorded and transmitted over a cellular or Wi-Fi connection to a patient’s provider, allowing for medication changes, if necessary, to prevent further health deterioration or hospitalization.

Critical Transition Theory Shows Flickering in Heart Before Atrial Fibrillation

Atrial fibrillation ranks among the most common heart conditions, and episodes are difficult to predict. Researchers have proposed a way to define cardiac state and have studied the dynamics before the cardiac rhythm changes from normal sinus to AF rhythm and vice versa. The work, appearing in Chaos and based on critical transition theory, looks to provide an early warning for those with paroxysmal atrial fibrillation with potential implications for future wearable devices.

Experimental cholesterol-lowering drug effective at lowering bad cholesterol, study shows

Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum dose of statin drugs, according to data of the ORION-10 trial presented Saturday, Nov. 16, at the American Heart Association’s Scientific Sessions 2019.

A King of Hearts

When Mick Jagger received an artificial heart valve via catheter, he made the transcatheter replacement valve famous. Iconic “Dr. Y” made it possible. Ajit Yoganathan’s lab has tested every valve on the market for quality, and his analyses shaped the industry and its designs, including of the valve in Jagger’s chest.